BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Enzon Pharmaceuticals (Piscataway, New Jersey) 

Research & Development Facility
20 Kingsbridge Road
Piscataway  New Jersey  08854-3998  U.S.A.
Phone: 732-980-4500 Fax: 732-980-5911


SEARCH JOBS




Industry
Biotechnology






 Company News
Enzon Pharmaceuticals, Inc. (ENZN) Concludes Review of Possible Asset Sales, Sale of the Company; Announces $1.60 Special Dividend and Periodic Royalty Dividends 4/24/2013 10:11:38 AM
Enzon Pharmaceuticals, Inc. (ENZN) Reports Fourth Quarter and Full Year 2012 Results 3/19/2013 8:59:56 AM
Enzon Pharmaceuticals (Piscataway, New Jersey) (ENZN) Announces Special Dividend 11/30/2012 10:38:00 AM
Enzon Pharmaceuticals (Piscataway, New Jersey) (ENZN) Announces Two Oral Presentations at the Symposium of Drug Delivery Systems in Nanjing, China 11/8/2012 9:22:19 AM
Enzon Pharmaceuticals (Piscataway, New Jersey) (ENZN) Reports Second Quarter 2012 Results 8/1/2012 8:45:11 AM
Enzon Pharmaceuticals (Piscataway, New Jersey) (ENZN) Announces Data From Phase I Study of PEG-SN38 in Pediatric Neuroblastoma and Other Solid Tumors Presented at 2012 Advances in Neuroblastoma Research Conference 6/19/2012 10:33:49 AM
Enzon Pharmaceuticals, Inc. (ENZN) and Hisun Announce Strategic Alliance for Enzon's Customized PEGylation Linker Technology and Licensing Agreement for PEG-SN38 in China 5/7/2012 8:51:56 AM
Enzon Pharmaceuticals, Inc. (ENZN) Reports First Quarter 2012 Results 5/2/2012 8:27:40 AM
Enzon Pharmaceuticals (Piscataway, New Jersey) (ENZN) Presents Clinical and Preclinical Data on mRNA Antagonists at 2011 American Association for Cancer Research-National Cancer Institute-European Organization for Research and Treatment of Cancer Meeting 11/14/2011 9:09:37 AM
Enzon Pharmaceuticals (Piscataway, New Jersey) (ENZN) Reports 3rd Quarter 2011 Results 11/4/2011 8:18:54 AM
12345678910